RR

Ranga Rao Baru

Active Director Director DIN 08776351
DIN 08776351 First appointment Jun 2020 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2020
Shareholding value •••• Premium profile

About Ranga Rao Baru

Data last updated:

Ranga Rao Baru is a Director at Vaksindo Animal Health Private Limited (since 2020). The company operates in Pharma. Vaksindo Animal Health Private Limited reported revenue of ₹74.16 Cr (FY 2025).

DIN 08776351
Primary Designation Director
Industry Pharma
First Appointment 29 Jun 2020
Oldest Company Age 8 yrs
Largest company Vaksindo Animal Health Private Limited · ₹74.16 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director29 Jun 20202018₹74.16 Cr (FY 2025)Active

Board colleagues of Ranga Rao Baru

Directorship timeline

Open interactive timeline →
Vaksindo Animal Health Private Limited
Premium access

Shareholding and investment profile for Ranga Rao Baru

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ranga Rao Baru

Ranga Rao Baru currently holds 1 directorship: Vaksindo Animal Health Private Limited (Director, since 29 Jun 2020, revenue ₹74.16 Cr (FY 2025)).

Ranga Rao Baru was first appointed on 29 Jun 2020 as Director at Vaksindo Animal Health Private Limited.

The current boards of Ranga Rao Baru's companies include Gabriella Santosa (Vaksindo Animal Health Private Limited), Teguh Yodiantara Prajitno (Vaksindo Animal Health Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available